维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="MOSCATIELLO S"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Obesity- associated liver disease显示文摘	Marchesini G Moscatiello S Di Domizio S	2008	J Clin Endoerinol Metab2008，93，111：	1
2	Insulin resistance in nonalcoholic fatty liver disease 显示文摘	Bugianesi E Moscatiello S Ciaravella MF	2010	Curt Pharm Des2010，16，17：	1
3	Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease 显示文摘	Villanova N Moscatiello S Ramilli S	2005	Hepatology2005，42，：	1
4	Immunopharmacological properties of flavonoids显示文摘	M.T.L Ielpo A Basile R Miranda V Moscatiello C Nappo S Sorbo E Laghi M.M Ricciardi L Ricciardi M.L Vuotto	2000	Fitoterapia2000，，：	1
5	Insulin re- sistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH 显示文摘	Montesi L Mazzotti A Moscatiello S	2013	Hepatol Int2013，7，2：	1
6	Diabetes and liver disease:an ominous association显示文摘	Moscatiello S Manini R Marchesini G	2007	Nutr Metab Cardiovasc Dis2007，17，1：	1
7	lnsulin resistance in nonalcoholic fatty liver disease 显示文摘	Bugianesi E Moscatiello S Ciaravella MF	2010	Curr Pharm Des2010，16，17：	1
8	Diabetes and liver disease:an ominous association显示文摘	Moscatiello S Manini R Marchesini G	2007	Nutr Matab Cardiovasc Dis2007，17，1：	1
9	Diabetes and liver disease: an ominous association显示文摘	Moscatiello S Manini R Marchesini G	2007	Nutr Metab Cardiovasc Dis2007，17，1：	1
10	Insulin resist- ance in nonalcoholic fatty liver disease 显示文摘	Bugianesi E Moscatiello S Ciaravella MF	2010	Curr Pharm Des2010，16，17：	1
11	Immunopharmacological properties of flavonoids 显示文摘	IELPO M T L BASILE A MIRANDA R MOSCATIELLO V NAPPO C SORBO S LAGHI E RICCIARDI M M RICCIARDI L VUOTYO M L	2000	Fitoterapia2000，71，：	1
12	Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease显示文摘	Villanova N Moscatiello S Ramilli S	2005	Hepatology2005，42，：	1
13	Managing the combina- tion of nonalcoholic fatty liver disease and metabolic syndrome 显示文摘	Moscatiello S Di Luzio R Sasdelli A S	2011	Expert Opin Pharmacother2011，12，17：	1
14	Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease显示文摘	Villanova N Moscatiello S Ramilli S	2005	Hepatology2005，42，：	1
15	Insulin resistance in nonalcoholic fatty liver disease显示文摘	Bugianesi E Moscatiello S Ciaravella MF	2010	Curr Pharm Des2010，16，17：	1
16	Managing the combina- tion of nonalcoholic fatty liver disease and metabolic syndrome 显示文摘	Moscatiello S Di Luzio R Sasdelli A S	2011	Expert Opin Pharmacother2011，12，17：	1
17	Obesity-associated liver disease 显示文摘	MARCHESINI G MOSCATIELLO S DI DOMIZIOS	2008	J ClinEndocrinol Metab2008，93，1：	1
18	Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease显示文摘	CENTIS E MOSCATIELLO S BUGIANESI E	2013	J Hepatol2013，58，4：	1
19	Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease 显示文摘	Villanova N Moscatiello S Ramilli S	2005	nepatology2005，42，2：	1
20	Diabetes and liver disease: an ominous association显示文摘	Moscatiello S Manini R Marchesini G	2007	Nutr Metab Cardiovasc Dis2007，17，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示